153 related articles for article (PubMed ID: 35572479)
21. Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).
Depietri L; Marietta M; Scarlini S; Marcacci M; Corradini E; Pietrangelo A; Ventura P
Intern Emerg Med; 2018 Jun; 13(4):527-534. PubMed ID: 29502330
[TBL] [Abstract][Full Text] [Related]
22. The incidence and risk factors of proximal lower extremity deep vein thrombosis without pharmacologic prophylaxis in critically ill surgical Taiwanese patients: A prospective study.
Lin TL; Liu WH; Lai WH; Chen YJ; Chang PH; Chen IL; Li WF; Liu YW; Ley EJ; Wang CC
J Intensive Care Soc; 2024 May; 25(2):140-146. PubMed ID: 38737310
[TBL] [Abstract][Full Text] [Related]
23. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature.
Tufano A; Guida A; Di Minno MN; Prisco D; Cerbone AM; Di Minno G
Semin Thromb Hemost; 2011 Apr; 37(3):267-74. PubMed ID: 21455860
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of chronic venous insufficiency and deep vein thrombosis in cirrhotic patients.
da Cruz Renó L; Tustumi F; Waisberg DR; Santos VR; Pinheiro RS; Macedo RA; Nacif LS; Ducatti L; De Martino RB; Trevisan AM; D'Albuquerque LC; Andraus W
Front Med (Lausanne); 2023; 10():1214517. PubMed ID: 37828947
[TBL] [Abstract][Full Text] [Related]
25. Venous thromboembolism in in-hospital cirrhotic patients: A systematic review.
da Cruz Renó L; Tustumi F; Waisberg DR; Rocha-Santos V; Pinheiro RS; Macedo RA; Nacif LS; Ducatti L; De Martino RB; Trevisan AM; Carneiro-D'Albuquerque L; Andraus W
Front Med (Lausanne); 2022; 9():1027882. PubMed ID: 36419795
[TBL] [Abstract][Full Text] [Related]
26. Nonadministration of pharmacologic venous thromboembolism prophylaxis is less common in hospitalized patients with COVID-19.
Varasteh Kia M; Lau BD; Owodunni OP; Kraus PS; Holzmueller CG; Hobson DB; Shaffer DL; Streiff MB; Haut ER
J Thromb Thrombolysis; 2021 Aug; 52(2):471-475. PubMed ID: 33507453
[TBL] [Abstract][Full Text] [Related]
27. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
[TBL] [Abstract][Full Text] [Related]
28. Reassessment of venous thromboembolism and bleeding risk in medical patients receiving VTE prophylaxis.
Tung EC; Yu SY; Shah K; Kinkade A; Tejani AM
J Eval Clin Pract; 2020 Feb; 26(1):18-25. PubMed ID: 31282101
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease.
Barclay SM; Jeffres MN; Nguyen K; Nguyen T
Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808
[TBL] [Abstract][Full Text] [Related]
30. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
[TBL] [Abstract][Full Text] [Related]
31. Impact of anesthesia modality and mechanical venous thromboembolism prophylaxis on the incidence of symptomatic deep venous thrombosis after TKA.
Ishii Y; Noguchi H; Sato J; Takayama S; Okada Y; Toyabe SI
J Clin Orthop Trauma; 2018; 9(2):142-145. PubMed ID: 29896017
[TBL] [Abstract][Full Text] [Related]
32. Determining the magnitude of surveillance bias in the assessment of lower extremity deep venous thrombosis: A prospective observational study of two centers.
Shackford SR; Cipolle MD; Badiee J; Mosby DL; Knudson MM; Lewis PR; McDonald VS; Olson EJ; Thompson KA; Van Gent JM; Zander AL
J Trauma Acute Care Surg; 2016 May; 80(5):734-9; discussion 740-1. PubMed ID: 26891155
[TBL] [Abstract][Full Text] [Related]
33. No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA.
Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
Clin Orthop Relat Res; 2019 Feb; 477(2):396-402. PubMed ID: 30624322
[TBL] [Abstract][Full Text] [Related]
34. High Prevalence and Mortality Associated with Upper Extremity Deep Venous Thrombosis in Hospitalized Patients at a Tertiary Care Center.
Rokosh RS; Ranganath N; Yau P; Rockman C; Sadek M; Berland T; Jacobowitz G; Berger J; Maldonado TS
Ann Vasc Surg; 2020 May; 65():55-65. PubMed ID: 31669473
[TBL] [Abstract][Full Text] [Related]
35. When Is It Safe to Start Pharmacologic Venous Thromboembolism Prophylaxis After Pelvic Fractures? A Prospective Study From a Level I Trauma Center.
Schellenberg M; Benjamin E; Inaba K; Heindel P; Biswas S; Mooney JL; Demetriades D
J Surg Res; 2021 Feb; 258():272-277. PubMed ID: 33039635
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
[TBL] [Abstract][Full Text] [Related]
37. Risk factors and pharmacologic prophylaxis for venous thromboembolism in elective spine surgery.
McLynn RP; Diaz-Collado PJ; Ottesen TD; Ondeck NT; Cui JJ; Bovonratwet P; Shultz BN; Grauer JN
Spine J; 2018 Jun; 18(6):970-978. PubMed ID: 29056565
[TBL] [Abstract][Full Text] [Related]
38. Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent.
Piazza G; Seddighzadeh A; Goldhaber SZ
Chest; 2007 Aug; 132(2):554-61. PubMed ID: 17573518
[TBL] [Abstract][Full Text] [Related]
39. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
[TBL] [Abstract][Full Text] [Related]
40. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
